APO Research
Talk to an analyst

APO RESEARCH · REPORT

Risperidone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Risperidone Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchRisperidone Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Risperidone Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Risperidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Risperidone Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Risperidone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Risperidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Risperidone include Ajanta Pharma, Amneal Pharmaceuticals, Apotex, Aurobindo Pharma, Celltrion, Dr. Reddy's Laboratories, Hikma, Lannett and Luye Pharma Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Risperidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Risperidone market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Risperidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Risperidone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Risperidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Risperidone Market by Company

Ajanta Pharma

Amneal Pharmaceuticals

Apotex

Aurobindo Pharma

Celltrion

Dr. Reddy's Laboratories

Hikma

Lannett

Luye Pharma Group

Torrent Pharmaceuticals

Tris Pharma

Janssen (Johnson & Johnson)

Sandoz

Risperidone Segment by Type

Tablet

Oral Solution

Risperidone Segment by Application

Schizophrenia

Bipolar Disorder

Risperidone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Risperidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Risperidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Oral Solution Table 3. Global Risperidone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Risperidone Sales by Type (2021-2026) & (W Units) Table 5. Global Risperidone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Risperidone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Risperidone Sales Market Share in Value by Type (2021-2026) Table 8. Global Risperidone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Risperidone Sales by Type (2027-2032) & (W Units) Table 10. Global Risperidone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Risperidone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Risperidone Sales Market Share in Value by Type (2027-2032) Table 13. Global Risperidone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Risperidone Sales by Type (2021-2026) & (W Units) Table 15. North America Risperidone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Risperidone Sales by Type (2021-2026) & (W Units) Table 17. Europe Risperidone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Risperidone Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Risperidone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Risperidone Sales by Type (2021-2026) & (W Units) Table 21. Latin America Risperidone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Risperidone Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Risperidone Sales by Type (2021-2026) & (US$ Million) Table 24. Risperidone Industry Trends Table 25. Risperidone Industry Drivers Table 26. Risperidone Industry Opportunities and Challenges Table 27. Risperidone Industry Restraints Table 28. Global Risperidone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Risperidone Revenue Market Share by Company (2021-2026) Table 30. Global Risperidone Sales by Company (2021-2026) & (W Units) Table 31. Global Risperidone Sales Share by Company (2021-2026) Table 32. Global Risperidone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Risperidone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Risperidone Major Company Production Sites and Headquarters Table 35. Global Risperidone Company, Product Type & Application Table 36. Global Risperidone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Risperidone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Risperidone Sales by Region (2021-2026) & (W Units) Table 41. Global Risperidone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Risperidone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Risperidone Sales Market Share in Value by Region (2021-2026) Table 44. Global Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Risperidone Sales by Region (2027-2032) & (W Units) Table 46. Global Risperidone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Risperidone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Risperidone Sales Market Share in Value by Region (2027-2032) Table 49. Global Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Risperidone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Risperidone Sales by Application (2021-2026) & (W Units) Table 52. Global Risperidone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Risperidone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Risperidone Sales Market Share in Value by Application (2021-2026) Table 55. Global Risperidone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Risperidone Sales by Application (2027-2032) & (W Units) Table 57. Global Risperidone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Risperidone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Risperidone Sales Market Share in Value by Application (2027-2032) Table 60. Global Risperidone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Risperidone Sales by Application (2021-2026) & (W Units) Table 62. North America Risperidone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Risperidone Sales by Application (2021-2026) & (W Units) Table 64. Europe Risperidone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Risperidone Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Risperidone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Risperidone Sales by Application (2021-2026) & (W Units) Table 68. Latin America Risperidone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Risperidone Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Risperidone Sales by Application (2021-2026) & (US$ Million) Table 71. Ajanta Pharma Company Information Table 72. Ajanta Pharma Business Overview Table 73. Ajanta Pharma Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Ajanta Pharma Risperidone Product Portfolio Table 75. Ajanta Pharma Recent Development Table 76. Amneal Pharmaceuticals Company Information Table 77. Amneal Pharmaceuticals Business Overview Table 78. Amneal Pharmaceuticals Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amneal Pharmaceuticals Risperidone Product Portfolio Table 80. Amneal Pharmaceuticals Recent Development Table 81. Apotex Company Information Table 82. Apotex Business Overview Table 83. Apotex Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Apotex Risperidone Product Portfolio Table 85. Apotex Recent Development Table 86. Aurobindo Pharma Company Information Table 87. Aurobindo Pharma Business Overview Table 88. Aurobindo Pharma Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Aurobindo Pharma Risperidone Product Portfolio Table 90. Aurobindo Pharma Recent Development Table 91. Celltrion Company Information Table 92. Celltrion Business Overview Table 93. Celltrion Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Celltrion Risperidone Product Portfolio Table 95. Celltrion Recent Development Table 96. Dr. Reddy's Laboratories Company Information Table 97. Dr. Reddy's Laboratories Business Overview Table 98. Dr. Reddy's Laboratories Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Dr. Reddy's Laboratories Risperidone Product Portfolio Table 100. Dr. Reddy's Laboratories Recent Development Table 101. Hikma Company Information Table 102. Hikma Business Overview Table 103. Hikma Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hikma Risperidone Product Portfolio Table 105. Hikma Recent Development Table 106. Lannett Company Information Table 107. Lannett Business Overview Table 108. Lannett Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lannett Risperidone Product Portfolio Table 110. Lannett Recent Development Table 111. Luye Pharma Group Company Information Table 112. Luye Pharma Group Business Overview Table 113. Luye Pharma Group Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Luye Pharma Group Risperidone Product Portfolio Table 115. Luye Pharma Group Recent Development Table 116. Torrent Pharmaceuticals Company Information Table 117. Torrent Pharmaceuticals Business Overview Table 118. Torrent Pharmaceuticals Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Torrent Pharmaceuticals Risperidone Product Portfolio Table 120. Torrent Pharmaceuticals Recent Development Table 121. Tris Pharma Company Information Table 122. Tris Pharma Business Overview Table 123. Tris Pharma Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Tris Pharma Risperidone Product Portfolio Table 125. Tris Pharma Recent Development Table 126. Janssen (Johnson & Johnson) Company Information Table 127. Janssen (Johnson & Johnson) Business Overview Table 128. Janssen (Johnson & Johnson) Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Janssen (Johnson & Johnson) Risperidone Product Portfolio Table 130. Janssen (Johnson & Johnson) Recent Development Table 131. Sandoz Company Information Table 132. Sandoz Business Overview Table 133. Sandoz Risperidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Sandoz Risperidone Product Portfolio Table 135. Sandoz Recent Development Table 136. North America Risperidone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. North America Risperidone Sales by Country (2021-2026) & (W Units) Table 138. North America Risperidone Sales Market Share by Country (2021-2026) Table 139. North America Risperidone Sales Forecast by Country (2027-2032) & (W Units) Table 140. North America Risperidone Sales Market Share Forecast by Country (2027-2032) Table 141. North America Risperidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Risperidone Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Risperidone Market Share by Country (2021-2026) Table 144. North America Risperidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Risperidone Market Share Forecast by Country (2027-2032) Table 146. Europe Risperidone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Europe Risperidone Sales by Country (2021-2026) & (W Units) Table 148. Europe Risperidone Sales Market Share by Country (2021-2026) Table 149. Europe Risperidone Sales Forecast by Country (2027-2032) & (W Units) Table 150. Europe Risperidone Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Risperidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Risperidone Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Risperidone Market Share by Country (2021-2026) Table 154. Europe Risperidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Risperidone Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Risperidone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Risperidone Sales by Country (2021-2026) & (W Units) Table 158. Asia-Pacific Risperidone Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Risperidone Sales Forecast by Country (2027-2032) & (W Units) Table 160. Asia-Pacific Risperidone Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Risperidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Risperidone Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Risperidone Market Share by Country (2021-2026) Table 164. Asia-Pacific Risperidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Risperidone Market Share Forecast by Country (2027-2032) Table 166. Latin America Risperidone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 167. Latin America Risperidone Sales by Country (2021-2026) & (W Units) Table 168. Latin America Risperidone Sales Market Share by Country (2021-2026) Table 169. Latin America Risperidone Sales Forecast by Country (2027-2032) & (W Units) Table 170. Latin America Risperidone Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Risperidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Risperidone Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Risperidone Market Share by Country (2021-2026) Table 174. Latin America Risperidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Risperidone Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Risperidone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Risperidone Sales by Country (2021-2026) & (W Units) Table 178. Middle East and Africa Risperidone Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Risperidone Sales Forecast by Country (2027-2032) & (W Units) Table 180. Middle East and Africa Risperidone Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Risperidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Risperidone Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Risperidone Market Share by Country (2021-2026) Table 184. Middle East and Africa Risperidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Risperidone Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Risperidone Distributors List Table 189. Risperidone Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Risperidone Image Figure 2. Global Risperidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Risperidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Risperidone Sales (2021-2032) & (W Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Risperidone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Risperidone Market Share by Type 2025 VS 2032 Figure 11. North America Risperidone Sales Market Share in Volume by Type in 2025 Figure 12. North America Risperidone Sales Market Share in Value by Type in 2025 Figure 13. Europe Risperidone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Risperidone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Risperidone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Risperidone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Risperidone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Risperidone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Risperidone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Risperidone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Risperidone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Schizophrenia Image Figure 24. Global Schizophrenia Sales YoY Growth (2021-2032) & (W Units) Figure 25. Bipolar Disorder Image Figure 26. Global Bipolar Disorder Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Risperidone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Risperidone Market Share by Application 2025 VS 2032 Figure 29. North America Risperidone Sales Market Share in Volume by Application in 2025 Figure 30. North America Risperidone Sales Market Share in Value by Application in 2025 Figure 31. Europe Risperidone Sales Market Share in Volume by Application in 2025 Figure 32. Europe Risperidone Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Risperidone Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Risperidone Sales Market Share in Value by Application in 2025 Figure 35. Latin America Risperidone Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Risperidone Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Risperidone Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Risperidone Sales Market Share in Value by Application in 2025 Figure 39. North America Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Risperidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Risperidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Risperidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Risperidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Risperidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Risperidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Risperidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Risperidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Risperidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Risperidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Risperidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Risperidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Risperidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Risperidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Risperidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Risperidone Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Risperidone Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Schizophrenia
  • Bipolar Disorder
Companies covered
  • Ajanta Pharma
  • Amneal Pharmaceuticals
  • Apotex
  • Aurobindo Pharma
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hikma
  • Lannett
  • Luye Pharma Group
  • Torrent Pharmaceuticals
  • Tris Pharma
  • Janssen (Johnson & Johnson)
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Risperidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Risperidone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Risperidone Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Oral Solution
  8. 1.4 Global Risperidone Market Size by Type
  9. 1.4.1 Global Risperidone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Risperidone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Risperidone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Risperidone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Risperidone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Risperidone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Risperidone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Risperidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Risperidone Industry Trends
  2. 2.2 Risperidone Industry Drivers
  3. 2.3 Risperidone Industry Opportunities and Challenges
  4. 2.4 Risperidone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Risperidone Revenue (2021-2026)
  2. 3.2 Global Top Players by Risperidone Sales (2021-2026)
  3. 3.3 Global Top Players by Risperidone Price (2021-2026)
  4. 3.4 Global Risperidone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Risperidone Major Company Production Sites & Headquarters
  6. 3.6 Global Risperidone Company, Product Type & Application
  7. 3.7 Global Risperidone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Risperidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Risperidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Risperidone Tier 1, Tier 2, and Tier 3
4 Risperidone Regional Status and Outlook
  1. 4.1 Global Risperidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Risperidone Historic Market Size by Region
  3. 4.2.1 Global Risperidone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Risperidone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Risperidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Risperidone Forecasted Market Size by Region
  7. 4.3.1 Global Risperidone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Risperidone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Risperidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Risperidone by Application
  1. 5.1 Risperidone Market by Application
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Bipolar Disorder
  4. 5.2 Global Risperidone Market Size by Application
  5. 5.2.1 Global Risperidone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Risperidone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Risperidone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Risperidone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Risperidone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Risperidone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Risperidone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Risperidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ajanta Pharma
  2. 6.1.1 Ajanta Pharma Company Information
  3. 6.1.2 Ajanta Pharma Business Overview
  4. 6.1.3 Ajanta Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ajanta Pharma Risperidone Product Portfolio
  6. 6.1.5 Ajanta Pharma Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Risperidone Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Apotex
  14. 6.3.1 Apotex Company Information
  15. 6.3.2 Apotex Business Overview
  16. 6.3.3 Apotex Risperidone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apotex Risperidone Product Portfolio
  18. 6.3.5 Apotex Recent Developments
  19. 6.4 Aurobindo Pharma
  20. 6.4.1 Aurobindo Pharma Company Information
  21. 6.4.2 Aurobindo Pharma Business Overview
  22. 6.4.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Aurobindo Pharma Risperidone Product Portfolio
  24. 6.4.5 Aurobindo Pharma Recent Developments
  25. 6.5 Celltrion
  26. 6.5.1 Celltrion Company Information
  27. 6.5.2 Celltrion Business Overview
  28. 6.5.3 Celltrion Risperidone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Celltrion Risperidone Product Portfolio
  30. 6.5.5 Celltrion Recent Developments
  31. 6.6 Dr. Reddy's Laboratories
  32. 6.6.1 Dr. Reddy's Laboratories Company Information
  33. 6.6.2 Dr. Reddy's Laboratories Business Overview
  34. 6.6.3 Dr. Reddy's Laboratories Risperidone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dr. Reddy's Laboratories Risperidone Product Portfolio
  36. 6.6.5 Dr. Reddy's Laboratories Recent Developments
  37. 6.7 Hikma
  38. 6.7.1 Hikma Company Information
  39. 6.7.2 Hikma Business Overview
  40. 6.7.3 Hikma Risperidone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hikma Risperidone Product Portfolio
  42. 6.7.5 Hikma Recent Developments
  43. 6.8 Lannett
  44. 6.8.1 Lannett Company Information
  45. 6.8.2 Lannett Business Overview
  46. 6.8.3 Lannett Risperidone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lannett Risperidone Product Portfolio
  48. 6.8.5 Lannett Recent Developments
  49. 6.9 Luye Pharma Group
  50. 6.9.1 Luye Pharma Group Company Information
  51. 6.9.2 Luye Pharma Group Business Overview
  52. 6.9.3 Luye Pharma Group Risperidone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Luye Pharma Group Risperidone Product Portfolio
  54. 6.9.5 Luye Pharma Group Recent Developments
  55. 6.10 Torrent Pharmaceuticals
  56. 6.10.1 Torrent Pharmaceuticals Company Information
  57. 6.10.2 Torrent Pharmaceuticals Business Overview
  58. 6.10.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Torrent Pharmaceuticals Risperidone Product Portfolio
  60. 6.10.5 Torrent Pharmaceuticals Recent Developments
  61. 6.11 Tris Pharma
  62. 6.11.1 Tris Pharma Company Information
  63. 6.11.2 Tris Pharma Business Overview
  64. 6.11.3 Tris Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tris Pharma Risperidone Product Portfolio
  66. 6.11.5 Tris Pharma Recent Developments
  67. 6.12 Janssen (Johnson & Johnson)
  68. 6.12.1 Janssen (Johnson & Johnson) Company Information
  69. 6.12.2 Janssen (Johnson & Johnson) Business Overview
  70. 6.12.3 Janssen (Johnson & Johnson) Risperidone Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Janssen (Johnson & Johnson) Risperidone Product Portfolio
  72. 6.12.5 Janssen (Johnson & Johnson) Recent Developments
  73. 6.13 Sandoz
  74. 6.13.1 Sandoz Company Information
  75. 6.13.2 Sandoz Business Overview
  76. 6.13.3 Sandoz Risperidone Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sandoz Risperidone Product Portfolio
  78. 6.13.5 Sandoz Recent Developments
7 North America by Country
  1. 7.1 North America Risperidone Sales by Country
  2. 7.1.1 North America Risperidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Risperidone Sales by Country (2021-2026)
  4. 7.1.3 North America Risperidone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Risperidone Market Size by Country
  6. 7.2.1 North America Risperidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Risperidone Market Size by Country (2021-2026)
  8. 7.2.3 North America Risperidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Risperidone Sales by Country
  2. 8.1.1 Europe Risperidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Risperidone Sales by Country (2021-2026)
  4. 8.1.3 Europe Risperidone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Risperidone Market Size by Country
  6. 8.2.1 Europe Risperidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Risperidone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Risperidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Risperidone Sales by Country
  2. 9.1.1 Asia-Pacific Risperidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Risperidone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Risperidone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Risperidone Market Size by Country
  6. 9.2.1 Asia-Pacific Risperidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Risperidone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Risperidone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Risperidone Sales by Country
  2. 10.1.1 South America Risperidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Risperidone Sales by Country (2021-2026)
  4. 10.1.3 South America Risperidone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Risperidone Market Size by Country
  6. 10.2.1 South America Risperidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Risperidone Market Size by Country (2021-2026)
  8. 10.2.3 South America Risperidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Risperidone Sales by Country
  2. 11.1.1 Middle East and Africa Risperidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Risperidone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Risperidone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Risperidone Market Size by Country
  6. 11.2.1 Middle East and Africa Risperidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Risperidone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Risperidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Risperidone Value Chain Analysis
  2. 12.1.1 Risperidone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Risperidone Production Mode & Process
  7. 12.2 Risperidone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Risperidone Distributors
  10. 12.2.3 Risperidone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst